Volume 16, Number 8—August 2010
Pandemic (H1N1) 2009 Vaccination and Class Suspensions after Outbreaks, Taipei City, Taiwan
In Taipei City, class suspensions were implemented beginning September 1, 2009 when transmission of pandemic (H1N1) 2009 infection was suspected. The uptake rate of pandemic (H1N1) 2009 vaccination (starting on November 16, 2009) among students 7–18 years of age was 74.7%. Outbreaks were mitigated after late November 2009.
As of April 25, 2010, >214 countries have reported laboratory confirmed cases of pandemic (H1N1) 2009, including >17,919 deaths. Preparedness measures such as having substantial antiviral drug stockpiles for treatment and chemoprophylaxis and implementation of vaccination programs are considered crucial for effective control of the pandemic (1,2). In many countries, vaccination programs for pandemic (H1N1) 2009 were implemented by the end of 2009.
The US Centers for Disease Control and Prevention (CDC) recommends that nonpharmaceutical interventions should be implemented to reduce influenza transmission between persons after an outbreak and before vaccination programs begin (3). During the 1918–19 and 2009 influenza pandemics, class suspension and school closures, either reactively following outbreaks or proactively at a regional level, were implemented by many countries (4–8). CDC guidance suggests that during an influenza outbreak, policymakers should weigh the advantages and disadvantages of school closures before making a decision (9).
In Taiwan, persons were confirmed to have pandemic (H1N1) 2009 infection if they had an acute febrile respiratory illness with an epidemiologic link and a positive test result for pandemic (H1N1) 2009. From June 1, 2009, through January 29, 2010, a total of 3,159 patients having documented pandemic (H1N1) 2009 infections were reported to the Taiwan Centers for Disease Control (Taiwan CDC) (10). Of these patients, 887 (28.1%) were hospitalized and 39 (4.4%) died (Figure 1, panel A). In Taipei City, 117 hospitalized patients infected with pandemic (H1N1) 2009 virus were reported, and 4 patients (3.4%) died during the same period. Patients <18 years of age accounted for 51.9% and 47.9% of all hospitalized patients in Taiwan and Taipei City, respectively (Figure 1, panel A) (10).
In Taiwan, a 2-3-5 intervention policy for class suspension was implemented beginning September 1 (week 35 of 2009) for all students <18 years of age when transmission of influenza-like illness or influenza A/B virus infection (identified by positive rapid antigen test [RAT] for influenza A/B) was suspected (11). Three commercial kits were available: QuickVue Influenza A+B (Quidel Corporation, San Diego, CA, USA), BD Directogen EZ Flu A+B (Becton Dickinson, Sparks, MD, USA), and BinaxNOW Influenza A&B (BinaxNOW, Portland, ME, USA) (11). Under the 2-3-5 policy, any class was suspended if >2 students were noted to have a positive RAT result or confirmed pandemic (H1N1) 2009 within 3 days. Students from suspended classes were asked to stay home for at least 5 days before returning to school. In addition, students’ temperatures were checked at the entrance of each school during the pandemic; if any student’s temperature was >38oC, the student was suspended.
Two pandemic (H1N1) 2009 vaccines were available: Focetria (Novartis, Basel, Switzerland, available since November 1, 2009) and AdimFlu-S (Adimmune Corporation, Taichung, Taiwan, available since November 16, 2009). Vaccination of front-line healthcare personnel began November 2, 2009; infants >6 months and <1 year received vaccination beginning November 11, 2009. Beginning November 16, 2009, pregnant women, preschool children 1–6 years of age and students 7–12 years of age were vaccinated. Students 13–15 years of age (since November 23, 2009) and 16–18 years of age (since November 30, 2009) (Figure 1, panel B), and persons with major illness or injury were vaccinated simultaneously (10). For children 6 months to 9 years of age, a second dose of vaccine was recommended with an interval of at least 3 weeks (10). For this age group, coverage rate of the vaccine in this report included those who had received at least 1 dose of vaccine. Immunization with pandemic (H1N1) 2009 vaccines was free and voluntary.
By January 29, 2010, less than half (5.6 million) of the planned doses (12 million) of pandemic (H1N1) 2009 vaccine had been administered. The overall coverage of the vaccine in Taiwan (population ≈23 million) was ≈24.3%; the rate was 21.8% for Taipei City (population 2.6 million). Coverage rates of pandemic (H1N1) 2009 vaccine for different age groups as of January 29, 2010, in Taipei City are shown in Figure 1, panel B. Overall, the coverage rate of the vaccine for school students 7–18 years of age was 271,460/363,603 (74.7%) as of January 29, 2010. The coverage rate for younger children (<6 years of age) and persons 19–24 years of age was 30.3% (first dose) and 3.1%, respectively (10).
As of January 29, 2010, a total of 1,708 classes in Taipei City’s elementary/primary, junior, and senior high schools had been suspended (Figure 2). The peak number of class suspensions (without school closures) occurred during September and November 2009, and no class was suspended after week 4 of 2010 (10).
In Taipei City, a total of 171 hospitalized patients infected with influenza viruses were identified from June 1, 2009, through January 29, 2010. These included 117 hospitalized patients infected with pandemic (H1N1) 2009 (Figure 2) (11). The pandemic (H1N1) 2009–related death rates were 1.54 and 1.78 per 1 million population in Taipei City and Taiwan, respectively; the death rate for Taiwan was the third lowest among the 32 members and observers of the Organization for Economic Cooperation and Development (12). Three waves of influenza were identified with activities that paralleled the intensity of class suspensions (Figure 2).
Although only about one fifth of the population in Taipei City had received pandemic (H1N1) 2009 vaccination, the number of hospitalized patients with pandemic (H1N1) 2009 declined remarkably after mid-November to December 2009; no cases were reported after January 29, 2010. The rationale of the 2-3-5 intervention policy in Taiwan was based on the incubation period of seasonal influenza. If influenza developed in 2 students in the same class within 3 days, it was anticipated that the virus had already been spread within the class. Because influenza virus shedding begins 24 hours before illness onset, we assumed that a 5-day observation period should detect all infected classmates.
The classroom structure in Taiwan’s middle schools and high schools is different from western countries and referred to as a “platoon” system. A group of students are placed together in a specific homeroom with a core teacher who also provides counseling to students and performs administrative work. Other teachers who specialize in different subjects move from class to class for teaching. The core teacher and administrative officials can audit off-school activities of each student through information technology.
Class suspensions or school closures alone may not be able to quell an epidemic, but these nonpharmaceutical interventions may be able to provide additional time to prepare for vaccination (5–8). Children, especially older students in middle or high school, play a primary role in transmission of influenza within schools, families, and communities and should be a key target group for vaccination (11,13,14). In our study, the number of class suspensions also decreased concurrently with the declining trend of hospitalized patients with pandemic (H1N1) 2009. Implementation of a vaccination policy for students, which began in mid-November (week 47), resulted in a remarkable decline of the third wave of pandemic (H1N1) 2009 two weeks later (week 49). This scenario suggests that the high vaccine coverage rate among students 6–18 years of age, as well as the 2-3-5 intervention policy, might have contributed to the rapid mitigation and subsequent cessation of the outbreak.
The results of our study demonstrate a more effective mitigation strategy to control influenza outbreaks during the wait for vaccines. Citywide class suspensions in Taipei City and the high uptake rate of vaccination among students may have had a combined effect in ending the influenza outbreaks.
Dr Hsueh is a professor in the departments of Laboratory Medicine and Internal Medicine of National Taiwan University Hospital and National Taiwan University College of Medicine. His research interests include molecular epidemiology and mechanisms of antimicrobial drug–resistant bacteria and emerging infections.
- Hui DS, Lee N, Chan PK. Clinical management of pandemic (H1N1) infection. Chest. 2010;137:916–25.
- Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT. Modelling mitigation strategies for pandemic (H1N1) 2009. CMAJ. 2009;181:673–80.
- Bell DM; World Health Organization Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis. 2006;12:88–94.
- Markel H, Lipman HB, Navarro JA, Sloan A, Michalsen JR, Stern AM, Nonpharmaceutical interventions implemented by US cities during the 1918–1919 influenza pandemic. JAMA. 2007;298:644–54.
- House T, Baguelin M, van Hoek AJ, Flasche S, White P, Sadique MZ, Can reactive school closures help critical care provision during the current influenza pandemic? PLoS Curr Influenza. 2009:RRN1119.
- Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, Closure of schools during an influenza pandemic. Lancet Infect Dis. 2009;9:473–81.
- Wu JT, Cowling BJ, Lau EHY, Ip DKM, Ho LM, Tsang T, School closure and mitigation of pandemic (H1N1). Hong Kong. [Epub ahead of print]. Emerg Infect Dis. 2009;2010.
- Kawaguchi R, Miyazono M, Noda T, Takayama Y, Sasai Y, Iso H. Influenza (H1N1) 2009 outbreak and school closure, Osaka Prefecture, Japan. Emerg Infect Dis. 2009;15:1685.
- Centers for Disease Control and Prevention. CDC guidance for state and local public health officials and school administrators for school (K-12) responses to influenza during the 2009–2010 school year [cited 2009 Oct 27]. http://www.cdc.gov/h1n1flu/schools/schoolguidance.htm
- Center for Disease Control, Department of Health, Executive Yuan, Taiwan. Reports on H1N1 Central Epidemic Command Center (CECC) 2010 [cited 2010 Feb 18]. http://www.cdc.gov.tw
- Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375:1100–8.
- Central Epidemic Command Center. Update on pandemic (H1N1) 2009 infections in humans [cited 2010 Feb 21]. http://flu.cdc.gov.tw/public/Data/0222106371.pdf
- Yen MY, Wu T-SJ, Chiu AW-H, Wong WW, Wang PE, Chan TC, Taipei's use of a multi-channel mass risk communication program to rapidly reverse an epidemic of highly communicable disease. PLoS ONE. 2009;4:e7962.
- Glass LM, Glass RJ. Social contact networks for the spread of pandemic influenza in children and teenagers. BMC Public Health. 2008;8:61.[REMOVED HYPERLINK FIELD]
- Figure 1. A) Incidence of hospitalization among patients infected with pandemic (H1N1) 2009 in each age group in Taipei City and throughout Taiwan as of week 4, 2010. B) Pandemic (H1N1)...
- Figure 2. Weekly number of class suspensions (including nursery schools, kindergartens, elementary/primary schools, and junior and senior high schools) and new hospitalized patients caused by pandemic (H1N1) 2009, confirmed by real-time...
Suggested citation for this article: Hsueh P-R, Lee P-I, Wen-Hsiang Chiu A, Yen M-Y. Pandemic (H1N1) 2009 vaccination and class suspensions after outbreaks, Taipei City, Taiwan. Emerg Infect Dis [serial on the Internet]. 2010 Aug [date cited]. http://wwwnc.cdc.gov/eid/article/16/8/10-0310
Please use the form below to submit correspondence to the authors or contact them at the following address:
Muh-Yong Yen, Department of Disease Control and Prevention, Taipei City Hospital, Taipei City Government, Taipei, Taiwan
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: March 30, 2011
- Page last updated: March 30, 2011
- Page last reviewed: March 30, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)